Fundraising Fox

Biolattice Ophthalmics, Inc.

Philadelphia, US · Founded 2023 · Delaware corporation · 2 known investors

biolatticetech.com ↗

BioLattice develops engineered cornea tissue as an alternative to donor cornea for patients with corneal blindness and those waiting for transplants. The company focuses on tissue engineering to address the shortage of donor cornea supply in the global ophthalmology market.

BiotechHealthtechMedical Devices

Founders & leadership

AZAmelia Zellander
Amelia ZellanderinExecutive Officer, Director
LALinda Alunkal
Linda AlunkalExecutive Officer, Director
GJ
Gregory JacksonDirector

Investors · 2

Life Sciences Greenhouse InvestmentsHarrisburg · $250K – $500K
Robin Hood VenturesPhiladelphia · $250K – $1Mvia Pitou Devgon · inferred

Reported raises · per SEC filings

Form D private placements
▶$575KraisedMar 2026 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Gregory JacksonDirector
  • Amelia ZellanderExecutive Officer, Director
  • Linda AlunkalExecutive Officer, Director
Offering amount
$2.5M
Amount sold
$575K
First sale
Mar 2026
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.